presents
Wheeless' Textbook of Orthopaedics
Tracking Pixel
Search Site by Word
My Account

Psoriatic Arthritis



- See: Spondyloarthropathies:

- Discussion:
    - psoriasis affects 1-2 % of U.S. population & typically presents w/ well-defined erythematous scaly plaques;
    - only a minority of pts with psoriasis develop arthritis;
    - when arthritis develops, it most often is an asymmetrical oligoarthritis, which at times may be quite destructive;
    - some patients may develop spondylitis (usually will have HLA-B27 antigen);
    - incidence of MV prolapse is high ( > 50%);


- Clinical Presentation:
    - clinical course of psoriasis is long-term, w/ characteristic relapses & remissions;
    - age: presents in 3rd-4th decade;
    - gender: men and women are affected in equal numbers;
          - skin:
                  - circumscribed erythrematous maculopapules or silver scaling;
                  - activity of skin lesions may or may not correlate w/ of peripheral arthritis;
                  - skin lesions may appear similar to Reiter's Syndrome;
                  - subcutaneous nodules are absent;
                  - nail deformities: 80% of patients will have nail lesions, including nail pits and onycholysis;
          - joints:
                  - involves the small joints of feet and hands more than any other joint;
                  - dactylitis may involve degree of tenosynovitis as well;
                  - severe cases may progress to arthritis mutilans, w/ widespread destruction;
          - foot:
                  - calcaneal spurs, sclerosis, & periarticular erosions of MP joints;
                  - spontaneous fusions do not occur;
          - hand & wrist:
                  - may have fusiform swelling of digits & nail changes;
                  - asymmetric joint involvement which affects terminal IP joints;
                  - DIP joint involvement.
                  - marked tendency for hand joints to becomes stiff;
                  - MP joints:   become stiff in extension, rather than stiff in flexion as in RA;


- Radiographic Features:
    - cartilage loss & erosions resemble changes seen in RA;
    - IP Joints:
          - symmetrical bony involvement with a predilection for DIP joints;
          - erosive damage in the IP joints (presence of pencil-in-cup change);
          - jonit destruction, widened joint spaces, & well defined adjacent bony surfaces;
          - advanced cases reveal a "pencil in cup" deformity, tuft resorption, and eventual ankylosis;
          - interphalangeal joint of the great toe is often involved;
          - there is generally a lack of juxta-articular osteopenia;
          - erosions are often para-marginal (where as in RA erosions are marginal);
    - Spine & SI Joint:
          - beaklike nonmarginal syndesmophytes are found (also seen in Reiter's);
          - bilateral sacroilitis occurs in 10-30% of pts;
          - paraspinal ligamentous calcification or ossification may occur similar to AS;


- Labs:
    - RF & antinuclear AB test (ANA) are neg;


- Treatment:
    - non-steroidals and occasionally methotrexate or oral colchicine;
    - sulfasalazine 1-2 gm per day has excellent efficacy;
    - systemic steroids should be used with caution since these may cause skin lesions to become pustular;
    - topical treatments:
            - anthralin, corticosteroids, keratolytic agents;
    - DIP joints are frequently spontaneously fused;
    - nail deformity:
            - w/ pitting, longitudinal ridging, consider intralesional corticosteroids;
            - triamcinolone acetonide 5 mg/ml injected into nail fold q3-4 weeks;
    - postoperative infection rates are higher than seen w/ RA;




Total knee arthroplasty in patients with psoriasis.

Psoriatic arthritis in the hand.
    JH Rose and MR Belsky.   Hand Clinics. Vol 5. 1989. p 137-144.

The psoriatic hand.
    OA Kapasi et al.   J. Hand Surg. Vol 7-A. 1982. p 472-788.

Sulphasalazine in the management of psoriatic arthritis.
      SM Fraser et al.   Br J. Rheumatology. 1993. Vol 32(10) p 923-925.

Comparison of sulfasalazine and placebo in the treatment of psoriatic arthritis.
      DO Clegg et al.   Arthritis Rheum 1996. Vol 39(12). p 2013-2020.

Psoriatic arthritis: a quantitative overview of therapeutic options: the Psoriatic Arthritis Meta Analysis Study Group.
      G Jones.   Br. J. Rheumatology. Vol 36(1). 1997. p 95-99.

Sulphasalazine in psoriatic arthritis: a randomized, multicentre, placebo controled study.
      Combe, B. et al.   Br J. Rheumatology.   Vol 35(7). 1996. p 664-668.




















Original Text by Clifford R. Wheeless, III, MD.